• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期新冠病毒感染的非侵入性血流动力学特征

Non-invasive hemodynamic profile of early COVID-19 infection.

作者信息

Busana Mattia, Schiavone Marco, Lanfranchi Antonio, Battista Forleo Giovanni, Ceriani Elisa, Beatrice Cogliati Chiara, Gasperetti Alessio

机构信息

Department of Anesthesiology, University Medical Center Göttingen, Göttingen, Germany.

Department of Cardiology, ASST-Fatebenefratelli Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy.

出版信息

Physiol Rep. 2020 Oct;8(20):e14628. doi: 10.14814/phy2.14628.

DOI:10.14814/phy2.14628
PMID:33113285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7592880/
Abstract

INTRODUCTION

Little is known about the systemic and pulmonary macrohemodynamics in early COVID-19 infection. Echocardiography may provide useful insights into COVID-19 physiopathology.

METHODS

Twenty-three COVID-19 patients were enrolled in a medical ward. Gas exchange, transthoracic echocardiographic, and hemodynamic variables were collected.

RESULTS

Mean age was 57 ± 17 years. The patients were hypoxemic (PaO /FiO  = 273.0 ± 102.6 mmHg) and mildly hypocapnic (PaCO  = 36.2 ± 6.3 mmHg, pH = 7.45 ± 0.03). Mean arterial pressure was decreased (86.7 [80.0-88.3] mmHg). Cardiac index was elevated (4.32 ± 0.90 L∙min ∙m ) and the resulting systemic vascular resistance index low (1,458 [1358-1664] dyn∙s∙cm ∙m ). The right heart was morphologically and functionally normal, with pulmonary artery pressure (PAPm, 18.0 ± 2.9 mmHg) and Total Pulmonary Resistances (TPR, 2.3 [2.1-2.7] mmHg∙l ∙min ) within normal limits. When stratifying for SVRI, patients with an SVRI value below the cohort median had also more severe oxygenation impairment and lower TPR, despite a similar degree of CXR infiltrates. Oxygen delivery index in this group resulted supranormal.

CONCLUSIONS

In the early stages of COVID-19 infection the hemodynamic profile is characterized by a hyperdynamic circulatory state with high CI and low SVRI, while the right heart is functionally unaffected. Our findings suggest that hypoxemia, viral sepsis or peripheral shunting are possible mechanisms for the vasodilation that dominates at this stage of the disease and may itself worsen the gas exchange.

摘要

引言

关于新冠病毒病(COVID-19)早期感染时的全身和肺部宏观血流动力学情况,人们了解甚少。超声心动图可能为COVID-19的病理生理学提供有用的见解。

方法

23例COVID-19患者入住内科病房。收集气体交换、经胸超声心动图和血流动力学变量。

结果

平均年龄为57±17岁。患者存在低氧血症(动脉血氧分压/吸入氧分数值[PaO₂/FiO₂]=273.0±102.6mmHg)且轻度低碳酸血症(动脉血二氧化碳分压[PaCO₂]=36.2±6.3mmHg,pH=7.45±0.03)。平均动脉压降低(86.7[80.0 - 88.3]mmHg)。心脏指数升高(4.32±0.90L·min⁻¹·m⁻²),导致全身血管阻力指数降低(1458[1358 - 1664]dyn·s·cm⁻⁵·m²)。右心在形态和功能上正常,肺动脉压(平均肺动脉压[PAPm],18.0±2.9mmHg)和总肺阻力(TPR,2.3[2.1 - 2.7]mmHg·l⁻¹·min⁻¹)在正常范围内。按全身血管阻力指数(SVRI)分层时,SVRI值低于队列中位数的患者尽管胸部X线浸润程度相似,但也有更严重的氧合障碍和更低的TPR。该组的氧输送指数超常。

结论

在COVID-19感染的早期阶段,血流动力学特征为高动力循环状态,心脏指数高而全身血管阻力指数低,而右心功能未受影响。我们的研究结果表明,低氧血症、病毒血症或外周分流可能是该疾病此阶段主导血管舒张的机制,且其本身可能会使气体交换恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/a0adb474976d/PHY2-8-e14628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/5d3a88f2f7a6/PHY2-8-e14628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/eb57cf65bf58/PHY2-8-e14628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/a0adb474976d/PHY2-8-e14628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/5d3a88f2f7a6/PHY2-8-e14628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/eb57cf65bf58/PHY2-8-e14628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acf3/7592880/a0adb474976d/PHY2-8-e14628-g003.jpg

相似文献

1
Non-invasive hemodynamic profile of early COVID-19 infection.早期新冠病毒感染的非侵入性血流动力学特征
Physiol Rep. 2020 Oct;8(20):e14628. doi: 10.14814/phy2.14628.
2
Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial.泽卢科普兰治疗 COVID-19 所致急性低氧性呼吸衰竭患者的疗效(ZILU-COV):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Nov 19;21(1):934. doi: 10.1186/s13063-020-04884-0.
3
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies.COVID-19 导致呼吸衰竭的呼吸生理学与其他病因导致的 ARDS 的比较。
Crit Care. 2020 Aug 28;24(1):529. doi: 10.1186/s13054-020-03253-2.
4
Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.2019冠状病毒病患者临床特征对重症疾病的预测作用
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):536-541. doi: 10.11817/j.issn.1672-7347.2020.200384.
5
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.强化血小板抑制治疗可改善严重 COVID-19 合并高凝状态患者的低氧血症:一项病例对照、概念验证研究。
Pharmacol Res. 2020 Aug;158:104950. doi: 10.1016/j.phrs.2020.104950. Epub 2020 May 23.
6
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.沙利莫司汀治疗 COVID-19 所致急性低氧性呼吸衰竭患者(SARPAC):一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):491. doi: 10.1186/s13063-020-04451-7.
7
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
8
Hemodynamic response to prone ventilation in COVID-19 patients assessed with 3D transesophageal echocardiography.采用三维经食管超声心动图评估新冠病毒肺炎患者俯卧位通气时的血流动力学反应。
Intensive Care Med. 2020 Nov;46(11):2099-2101. doi: 10.1007/s00134-020-06217-w. Epub 2020 Aug 26.
9
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
10
[Position Paper for the State of the Art Application of Respiratory Support in Patients with COVID-19 - German Respiratory Society].[新型冠状病毒肺炎患者呼吸支持的最新应用立场文件 - 德国呼吸学会]
Pneumologie. 2020 Jun;74(6):337-357. doi: 10.1055/a-1157-9976. Epub 2020 Apr 22.

引用本文的文献

1
COVID-19. Biology, pathophysiology, and immunology: a pathologist view.新型冠状病毒肺炎(COVID-19)的生物学、病理生理学和免疫学:病理学家的视角。
Pathologica. 2023 Oct;115(5):248-256. doi: 10.32074/1591-951X-954.
2
Echocardiography in COVID-19 Pandemic: Clinical Findings and the Importance of Emerging Technology.COVID-19 大流行中的超声心动图:临床发现和新兴技术的重要性。
Card Electrophysiol Clin. 2022 Mar;14(1):71-78. doi: 10.1016/j.ccep.2021.10.007. Epub 2021 Oct 30.
3
Cardiac involvement in hospitalized patients with COVID-19 and its incremental value in outcomes prediction.

本文引用的文献

1
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病:生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
2
Liver histopathology in severe COVID 19 respiratory failure is suggestive of vascular alterations.严重 COVID-19 呼吸衰竭患者的肝脏组织病理学表现提示血管改变。
Liver Int. 2020 Sep;40(9):2110-2116. doi: 10.1111/liv.14601. Epub 2020 Jul 20.
3
Almitrine as a non-ventilatory strategy to improve intrapulmonary shunt in COVID-19 patients.
COVID-19 住院患者的心脏受累及其对预后预测的增量价值。
Sci Rep. 2021 Sep 30;11(1):19450. doi: 10.1038/s41598-021-98773-4.
4
Echocardiographic assessment of the right ventricle in COVID-19: a systematic review.超声心动图评估 COVID-19 患者右心室:系统评价。
Int J Cardiovasc Imaging. 2021 Dec;37(12):3499-3512. doi: 10.1007/s10554-021-02353-6. Epub 2021 Jul 22.
5
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime.上皮细胞和内皮细胞在新冠肺炎早期肺炎中的致病作用:同谋与共犯。
Mod Pathol. 2021 Aug;34(8):1444-1455. doi: 10.1038/s41379-021-00808-8. Epub 2021 Apr 21.
阿米三嗪作为一种改善新冠肺炎患者肺内分流的非通气策略。
Anaesth Crit Care Pain Med. 2020 Aug;39(4):467-469. doi: 10.1016/j.accpm.2020.05.013. Epub 2020 Jun 4.
4
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
5
Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.COVID-19 合并低氧性急性呼吸衰竭患者俯卧位通气的应用。
JAMA. 2020 Jun 9;323(22):2336-2338. doi: 10.1001/jama.2020.8255.
6
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.COVID-19 患者的尸检结果与静脉血栓栓塞:一项前瞻性队列研究。
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
7
Pulmonary Embolism in Patients With COVID-19: Awareness of an Increased Prevalence.2019冠状病毒病患者的肺栓塞:对患病率增加的认识
Circulation. 2020 Jul 14;142(2):184-186. doi: 10.1161/CIRCULATIONAHA.120.047430. Epub 2020 Apr 24.
8
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
9
SARS-CoV-2 and viral sepsis: observations and hypotheses.SARS-CoV-2 与病毒败血症:观察与假说。
Lancet. 2020 May 9;395(10235):1517-1520. doi: 10.1016/S0140-6736(20)30920-X. Epub 2020 Apr 17.
10
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis.新冠肺炎患者 ICU 中的高凝状态:血栓弹力描记图结果和其他止血参数报告。
J Thromb Haemost. 2020 Jul;18(7):1738-1742. doi: 10.1111/jth.14850. Epub 2020 Jun 24.